Skip to search.
 FTSE 100 Up 1.14%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
1.78 Up 0.01(0.28%) 14:32 - Nasdaq Real Time Price
Prev Close:1.77
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:4.50
Beta:1.54169
Earnings Date:8 Nov - 14 Nov (Est.)
Day's Range:1.75 - 1.78
52wk Range:1.30 - 2.68
Volume:19,479
Avg Vol (3m):1,673,970
Market Cap:431.78m
P/E (ttm):N/A
EPS (ttm):-0.44
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNAUp 0.28%431.78m
OREXUp 1.82%48.87m
GSKDown 0.11%104.31b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.88
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.35
Quarterly EPS Est (Sep-16) :-0.07
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):0.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors to address unmet medical needs in the United States and South Korea. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback